(AOF) – Pharnext announces a fundraising of 1.5 million euros through the issue of Oceane-BSA subscribed by Global Tech Opportunities 13. This biopharmaceutical company at an advanced clinical stage developing new therapies for neurodegenerative diseases without a satisfactory therapeutic solution specifies that “the participation of a shareholder holding 1% of the capital prior to this new drawing would be 0.66%”.
© 2023 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
